MAPK activation in mature cataract associated with Noonan syndrome
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Noonan syndrome is an autosomal, dominantly inherited disease; it is physically characterized by short stature, short neck, webbed neck, abnormal auricles, high arched palate, and cardiovascular malformation. Its pathological condition is thought to be due to a gain-of-function mutation in the Ras-mitogen-activated protein kinase (MAPK) signal transduction pathway. Eyelid abnormalities such as ocular hypertelorism and blepharoptosis are the most commonly observed eye complications. CASE PRESENTATION: We report a case of Noonan syndrome associated with mature cataract that required operation. A 42-year-old man was diagnosed with Noonan syndrome at the age of 1 year. He underwent an eye examination after complaining of decreased visual acuity in the right eye and was diagnosed with mature cataract, which was treated by cataract surgery. There were no intraoperative complications, and the postoperative course was uneventful. Protein analysis of lens capsule and epithelium at capsulorhexis showed MAPK cascade proteins such as ERK and p38MAPK were upregulated. An abnormality in the PTPN11 gene was also observed; a potential mechanism of cataract onset may be that opacity of the lens rapidly progressed due to abnormal activation of the Ras-MAPK signal transduction pathway. CONCLUSION: This case highlights the possible association of cataract formation with MAPK cascade protein upregulation in Noonan syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a case report of mature cataract in a patient with Noonan syndrome, a genetic gain-of-function RASopathy where, not surprisingly, ERK and p38 were found upregulated in the lens [ 212 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [212]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111 · cited 1×
“The classic MAPKs, ERKs, are principally activated in response to growth factors, whereas JNK and p38 are activated by various stresses, including TNF-α treatment, UV light, x-ray irradiation, heat-shock, and H2O2 treatment [12].”
BackgroundRAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · cited 1×
“The RAS/RAF/MEK/ERK pathway is the classical RAS-MAPK signaling pathway implicated in growth-factor mediated cell proliferation, differentiation, and death [16].”
BackgroundMutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,733 · cited 3×
“These genes are involved in several developmental processes that control morphology determination, organogenesis, synaptic plasticity, and growth [3-7].”
BackgroundRoberts, A. E., Allanson, J. E., Tartaglia, M., & Gelb, B. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61023-x · Cited by 793
Grouping of Multiple-Lentigines/LEOPARD and Noonan Syndromes on the PTPN11 Gene
Digilio, M. C., Conti, E., Sarkozy, A., Mingarelli, R., Dottorini, T., Marino, B., Pizzuti, A., & Dallapiccola, B. (2002) · The American Journal of Human Genetics · doi:10.1086/341528 · Cited by 421 · cited 2×
“; licensee BioMed Centra Commons Attribution License (http://creativec reproduction in any medium, provided the or 151100)) [4].”
BackgroundNoonan syndrome and clinically related disorders
Tartaglia, M., Gelb, B. D., & Zenker, M. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.09.002 · Cited by 414 · cited 3×
“Noonan-like syndromes comprising Costello syndrome (CS; OMIM 218040), cardiofaciocutaneous syndrome (CFCS, OMIM 115150), neurofibromatosis type 1 (NF1; OMIM 162200), and Legius syndrome (NFLS, OMIM 611431) are disorders clinically related to NS and also harbor mutations in HRAS, KRAS, NF1, BRAF, SPRED1, MEK1, and MEK2…”
BackgroundAssociated noncardiac malformations in children with congenital heart disease
Noonan, J. A. (1963) · Jornal de Pediatria · Cited by 383
The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders
Aoki, Y., Niihori, T., Narumi, Y., Kure, S., & Matsubara, Y. (2008) · Human Mutation · doi:10.1002/humu.20748 · Cited by 365 · cited 1×
“These genes are involved in several developmental processes that control morphology determination, organogenesis, synaptic plasticity, and growth [3-7].”
BackgroundClinical and molecular studies in a large Dutch family with Noonan syndrome
Van Der Burgt, I., Berends, E., Lommen, E., Van Beersum, S., Hamel, B., & Mariman, E. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320530213 · Cited by 285 · cited 1×
“This scoring system contains 6 categories with 2 alternatives in each category [11].”
MethodOcular manifestations of Noonan syndrome
Lee, N. B., Kelly, L., & Sharland, M. (1992) · Eye · doi:10.1038/eye.1992.66 · Cited by 102
Research works printed but not linked: 1
- Noonan JA, Ehmeke DA: Associated non-cardiac malformatons in children with congenital heart disease. J Paediatr. 1963, 63: 468-470.
Cited by
Therapeutic potential of targeting SHP2 in human developmental disorders and cancers
Shen, D., Chen, W., Zhu, J., Wu, G., Shen, R., Xi, M., & Sun, H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112117 · Cited by 73
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“There have also been reports of upregulated ERK1/2 and JNK signaling in induced cataract in rats [211], and a case report of mature cataract in a patient with Noonan syndrome, a genetic gainof-function RASopathy where, not surprisingly, ERK and p38 were found upregulated in the lens [212].”
BackgroundLiao, J., Su, X., Chen, P., Wang, X., Xu, L., Li, X., Thean, L., Tan, C., Tan, A. G., Tay, W.-T., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu315 · Cited by 46
“The association between MAPK cascade protein upregulation and cataract formation had been previously reported (34,35), while insulin and insulin-like growth factor had been shown to stimulate phosphatidylinositol 3-kinase in the lens and affect lens epithelial cell proliferation and differentiation (36).”
BackgroundOcular findings in Noonan syndrome: a retrospective cohort study of 105 patients
van Trier, D. C., van der Burgt, I., Draaijer, R. W., Cruysberg, J. R. M., Noordam, C., & Draaisma, J. M. T. (2018) · European Journal of Pediatrics · doi:10.1007/s00431-018-3183-1 · Cited by 45
“Keratoconus in NS is described in literature in two case reports [2, 7], iris coloboma is described two times [3, 6] and cataract is also described in a few patients with NS [5, 8].”
Ocular Manifestations of Noonan Syndrome
van Trier, D. C., Vos, A. M. C., Draaijer, R. W., van der Burgt, I., Draaisma, J. M. T., & Cruysberg, J. R. M. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.06.061 · Cited by 26
“Proptosis 1/56 (2) NR 1/18 (6) 9/35 (26) 11/109 (10) 1/25 (4)* Orbital dermoid cyst NR 1/10 (10) NR NR 1/10 (10) 0/25 (0) Nasolacrimal duct obstruction 1/56 (2) 2/10 (20) NR NR 3/66 (5) 0/25 (0) Strabismus and ocular motility Strabismus 28/58 (48) 6/10 (60) 12/18 (67) 5/35 (14) 51/121 (42) 10/25 (40) Esotropia 13/58 (…”
Metadata
- Authors
- Hashida, N., Ping, X., & Nishida, K.
- Affiliations
- Osaka University Hospital (JP)
- Corresponding author
- Hashida, Noriyasu
- Venue
- BMC Ophthalmology
- Published
- 2013-11-12
- Volume
- 13
- Issue
- 1
- Pages
- 70-70
- ISSN
- 1471-2415 (ISSN-L)
- PMC
- PMC3829809
- OpenAlex
- W1981256020
- Cited by
- 14
- References
- 21
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 1 · 2016: 1 · 2015: 1 · 2014: 3
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- BMC Ophthalmology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Health Sciences › Medicine › Ophthalmology › Intraocular Surgery and Lenses
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Keywords
- Noonan syndrome, mature cataract, MAPK signaling, RAS/MAPK pathway, PTPN11 mutation, ERK, p38 MAPK, lens capsule, lens epithelium, cataract surgery, eyelid abnormalities
- MeSH terms
- Adult, Cataract, Humans, Lens, Crystalline, Male, Noonan Syndrome, Mitogen-Activated Protein Kinase 1, MAP Kinase Signaling System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MAPK activation in mature cataract associated with Noonan syndrome. https://app.cochat.ai/papers/10.1186/1471-2415-13-70
- The paper
- Hashida, N., Ping, X., & Nishida, K. (2013). MAPK activation in mature cataract associated with Noonan syndrome. BMC Ophthalmology. https://doi.org/10.1186/1471-2415-13-70
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.